levofloxacin has been researched along with calcimycin in 1 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 11,946 | 40 | 444 |
| Protein | Taxonomy | levofloxacin (IC50) | calcimycin (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 1.41 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuhama, K; Mori, K; Satoh, H; Shibano, M; Takasuna, K | 1 |
1 other study(ies) available for levofloxacin and calcimycin
| Article | Year |
|---|---|
Differential response of mast cells separated from various organs and basophils of dogs to the fluoroquinolone antimicrobial levofloxacin.
Topics: Animals; Anti-Infective Agents; Basophils; Calcimycin; Connective Tissue; Dogs; Female; GTP-Binding Proteins; Histamine Release; Ionophores; L-Lactate Dehydrogenase; Levofloxacin; Liver; Male; Mast Cells; Mucous Membrane; Ofloxacin; Pertussis Toxin; Skin; Virulence Factors, Bordetella | 2001 |